Abiopharma

🔍 HARRISON MARK MALLOY (Director)

Company: Home Federal Bancorp, Inc. of Louisiana (HFBL)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock at $11.86 per share (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 56,772.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 5,466.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 1,822.00 | Footnotes: F2
• Sold 16,000 shares of Stock Option (Right to Buy) at $11.86 per share (Derivative)
  Date: 2026-03-20 | Code: M | Expires: 2030-11-11 | Exercise: 2025-11-11 | equity_swap_involved: 0 | shares_owned_after: 16,000.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 12,000 shares of Stock Option (Right to Buy) at $15.17 per share (Derivative)
  Date: 2026-03-20 | Code: H | Expires: 2035-12-18 | shares_owned_after: 12,000.00 | Footnotes: F4
• Holds 5,000 shares of Stock Option (Right to Buy) at $11.79 per share (Derivative)
  Date: 2026-03-20 | Code: H | Expires: 2034-07-24 | shares_owned_after: 5,000.00 | Footnotes: F5

Footnotes:

• F1: Includes 5,000 shares granted pursuant to the Issuer's 2025 Stock Incentive Plan that are vesting ratably over five years at 20% per year commencing on December 18, 2026.
• F2: The 1,822 shares are held jointly by the reporting person's spouse with her parents.
• F3: The options vested at a rate of 20% per year commencing November 11, 2021, and were fully vested and exercisable as of November 11, 2025.
• F4: The options are vesting at a rate of 20% per year commencing on December 18, 2026.
• F5: The options are vesting at a rate of 20% per year commencing on July 24, 2025.